A leader in diabetes innovation, education and research to improve patient care
At Park Nicollet International Diabetes Center, our mission is to ensure that every person with diabetes or at risk for diabetes receives the best possible care. We are known throughout the world for our experience and expertise in patient education, professional training, research, and models for patient-centered care and quality improvement. Our focus is on translating new research findings into clinical practice and discovering innovative ways to use technology to improve diabetes care.
International Diabetes Center (IDC) believes in a patient-centered, team approach to diabetes care. We focus on the relationship between the patient, provider and educator to ensure that each receives the information and tools they need to improve patient health.
Founded by Donnell D. Etzwiler, MD, in 1967, IDC continues to provide world-class diabetes care, education, publications and research that meet the needs of people with diabetes and their families. We continue to shape the community – and the world – to help people live well with diabetes.
IDC staff includes over 80 health care professionals involved in research and education, and who collaborate with other areas within Park Nicollet to ensure patients receive the best possible diabetes care.
For diabetes patient appointments and endocrinology information, please contact your Park Nicollet primary care doctor or the Endocrinology Department, or visit their pages on the Park Nicollet Web site.
Richard M. Bergenstal, MD, executive director
Richard Bergenstal, MD, is an adult endocrinologist and executive director of IDC. He is also clinical professor in the Department of Medicine at the University of Minnesota Medical School. In 2010, he served as president, science and medicine, of the American Diabetes Association (ADA), and in 2007, he was named ADA’s Outstanding Physician Clinician of the Year.
Dr. Bergenstal received his MD and endocrine training from the University of Chicago where he was assistant professor of medicine before joining IDC in 1983. His clinical research has focused on glucose control and diabetes complications. He serves as principal investigator of three National Institutes of Health trials – the Diabetes Control and Complications Trial (DCCT) in type 1 diabetes, and the Action to Control Cardiovascular Risk in Diabetes (ACCORD), and Glycemic Reduction Approaches in Diabetes (GRADE) studies in late and early onset type 2 diabetes. His clinical work focuses on optimizing patient-centered team care and the appropriate use of glucose monitoring and insulin therapy.
Glenn Matfin, MD, medical director
Glenn Matfin, MD, is an adult endocrinologist and the center’s medical director. Before joining IDC, he was senior staff physician at Joslin Diabetes Center and clinical associate professor at New York University. He received his MD and training from the University of Leeds, in the United Kingdom. In his fellowship, he worked for renowned diabetes expert Professor Sir George Alberti, which sparked an interest in diabetes.
After moving to the United States, Dr. Matfin worked with the Pima Indians in Phoenix, Arizona for the National Institutes of Health. He has designed more than 100 clinical trials involving more than 100,000 subjects, and has been involved in professional education programs for health care providers in the United States and globally.
Joan Bissen, executive director, Park Nicollet Institute